S- アデノシルホモシステインヒドローラゼの抑制は,p66shc媒介による酸化ストレス経路の表皮遺伝的調節によって内皮機能障害を誘発する.
PubMedで要約を見る
まとめ
この要約は機械生成です。S- アデノシルホモシステイン (SAH) 濃度の上昇は,p66shcをエピジェネティックに調節し,動脈硬化に寄与することで,内皮機能を損なう. この研究は,SAHと内皮損傷を結びつける新しいメカニズムを明らかにしています.
科学分野
- 心血管研究
- 分子生物学
- エピジェネティクス
背景
- S- アデノシルホモシステイン (SAH) の上昇は,心血管疾患と動脈硬化に関連しています.
- 内皮機能障害におけるSAHの特定の役割は不明である.
研究 の 目的
- 大動脈内皮機能障害におけるSAHの役割を調査する.
- SAHが誘発する内皮損傷の背後にある分子メカニズムを解明する.
主な方法
- SAHH阻害剤またはshRNAを使用したマウスモデル (apoE- / - マウス,SAHH+ / - マウス) でSAH濃度が上昇しました.
- 内皮機能,酸化窒素の生物利用性,酸化ストレスが評価されました.
- DNAメチル化および遺伝子発現 (p66shc,DNMT1) を含む表遺伝的変異はマウス主動脈とヒト細胞で分析された.
- 人間の研究では,冠動脈疾患の患者の血SAH濃度と内皮機能と遺伝子プロモーターメチル化が相関している.
主要な成果
- SAHHの抑制により,血のSAH濃度が上昇し,内皮に依存する血管拡張と窒素酸化物の生物利用性が低下した.
- SAHHの抑制は,p66shcプロモーターの低甲基化によって誘発された反応性酸素種生成とp66shc発現を引き起こした.
- DNAメチルトランスフェラーゼ1 (DNMT1) 発現はSAHH抑制によって抑制され,その過剰発現はp66shcアップレギュレーションを廃止した.
- 人体では,高濃度のSAHは,フローメディエーションによる膨張の減少と酸化ストレスの増加と相関する.
結論
- SAHHの抑制は,p66shc媒介の酸化ストレス経路の表遺伝子上調によって,SAHの上昇と内皮機能不全を引き起こす.
- この研究は,SAHに関連した動脈硬化に寄与する内皮損傷メカニズムに関する新しい洞察を提供します.
- SAHに関連する表遺伝的変異をターゲットにすることで,心臓血管疾患の治療戦略を提供することができます.
関連する概念動画
Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
In most mammals, females have two X chromosomes (XX) while males have an X and a Y chromosome (XY). The X chromosome contains significantly more genes than the Y chromosome. Therefore, to prevent an excess of X chromosome-linked gene expression in females, one of the two X chromosomes is randomly silenced during early development....
Epigenetic changes alter the physical structure of the DNA without changing the genetic sequence and often regulate whether genes are turned on or off. This regulation ensures that each cell produces only proteins necessary for its function. For example, proteins that promote bone growth are not produced in muscle cells. Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
X-chromosome...
Nitric oxide (NO), an inorganic gas, acts as a potent second messenger in most animal and plant tissues. NO diffuses out of the cells that produce it and enters the neighboring cells to generate a downstream response. NO synthase (NOS) catalyzes NO production by the deamination of the amino acid arginine. There are three isoforms of NOS. Endothelial cells have endothelial NOS (eNOS), nerve and muscle cells have neuronal NOS (nNOS), and macrophages produce inducible NOS (iNOS) upon exposure...
Lysosomes are the site for the degradation of macromolecules and biological polymers released during membrane trafficking events such as secretory, endocytic, autophagic, and phagocytic pathways. The membrane-enclosed area of the lysosome, called the lumen, contains hydrolytic enzymes active in an acidic environment. These acid hydrolases are functional at a pH between 4.5 and 5 and are involved in cellular processes such as cell signaling, energy metabolism, restoration of the plasma membrane,...
Biochemical reactions are occurring constantly in cells, converting starting substances to different products, usually with the help of enzymes that speed the reactions. Without enzymes, it would take far too long for most reactions to occur to be useful to the cell!
Since enzymes help control the rate of reactions, their activity is regulated so that appropriate amounts of starting materials, intermediate metabolites, and products are maintained in the cell. Excessive build-up or depletion of...
Guanine nucleotide-binding proteins (G-proteins), also known as GTPases, are a superfamily of proteins that regulate many cellular processes, such as cell signaling, vesicular transport, and the regulation of cell shape and motility. Mutation or dysfunction of these proteins can lead to disease. There are around 40,000 known G-proteins that can broadly be classified into two groups ‒ small G-proteins consisting of a single domain and large multi-domain G-proteins.
Large G-proteins,...

